Print Friendly, PDF & Email

NCT/Study#

NA /

GS-US-546-5857

Phase 3 Study To Evaluate The Safety And Efficacy Of Magrolimab In Combination With Azacitidine Versus Physician’s Choice Of Venetoclax In Combination With Azacitidine Or Intensive Chemotherapy In Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia (ENHANCE-2)

DISEASE GROUP:
Leukemia
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: